BRCA1 and intrahepatic cholangiocarcinoma: A recent study demonstrated that approximately 2% (7/357) of patients with primary liver cancer carried BRCA1/2 germline mutations, most of which (5/7) were intrahepatic cholangiocarcinoma.[14]